1. Home
  2. EQ vs LNZA Comparison

EQ vs LNZA Comparison

Compare EQ & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$1.28

Market Cap

89.4M

Sector

Health Care

ML Signal

N/A

Logo LanzaTech Global Inc.

LNZA

LanzaTech Global Inc.

N/A

Current Price

$3.81

Market Cap

77.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
EQ
LNZA
Founded
2017
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
89.4M
77.5M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
EQ
LNZA
Price
$1.28
$3.81
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $8.56
N/A
AVG Volume (30 Days)
★ 312.5K
56.2K
Earning Date
11-12-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 17.00
Revenue
$41,095,000.00
★ $55,845,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$0.23
Revenue Growth
N/A
★ 12.61
52 Week Low
$1.16
$3.91
52 Week High
$6.20
$44.00

Technical Indicators

Market Signals
Indicator
EQ
LNZA
Relative Strength Index (RSI) 40.62 29.38
Support Level $1.24 N/A
Resistance Level $1.51 $6.46
Average True Range (ATR) 0.12 0.40
MACD 0.01 -0.11
Stochastic Oscillator 15.79 0.00

Price Performance

Historical Comparison
EQ
LNZA

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

About LNZA LanzaTech Global Inc.

LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.

Share on Social Networks: